1. Development and Validation of a Concise Prediction Scoring System for Asian Lung Cancer Patients with EGFR Mutation Before Treatment
   Wenting An et al, 2022, Technology in Cancer Research & Treatment CrossRef
2. Notch signaling and targeted therapy in non-small cell lung cancer
   Jiajun Sun et al, 2024, Cancer Letters CrossRef
3. Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
   Man Wang et al, 2023, Frontiers in Pharmacology CrossRef
4. Silicon-substituted calcium phosphate promotes osteogenic-angiogenic coupling by activating the TLR4/PI3K/AKT signaling axis
   Yuanhang Kong et al, 2022, Journal of Biomaterials Applications CrossRef
5. Clinicopathological Characteristics and Prognosis Analysis of Lung Carcinoma With p40/TTF1 Coexpression and Lung Adenosquamous Carcinoma: Lung Carcinoma With p40/TTF1 Coexpression Is a Rare Tumor With High Metastatic Potential
   Rui Gao et al, 2024, International Journal of Surgical Pathology CrossRef
6. The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study
   Asmaa A. Helal et al, 2024, Journal of the Egyptian National Cancer Institute CrossRef
7. TP53, NOTCH2, and STK11 Mutations in a Rare Tumor of non-Small Cell Lung Carcinoma with Diffuse Coexpression of TTF1 and p40 in the Same Tumor Cells
   Xingmei Guo et al, 2023, International Journal of Surgical Pathology CrossRef
8. The potential mechanism of Fructus Ligustri Lucidi promoting osteogenetic differentiation of bone marrow mesenchymal stem cells based on network pharmacology, molecular docking and experimental identification
   Yuanhang Kong et al, 2022, Bioengineered CrossRef